Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Perspective Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
0 vs. Q2 2023
Shares held
36.5M
+3.62M (+11.0%) vs. Q2 2023
Total value
$9.99M
−$12.0M (−54.5%) vs. Q2 2023
New holders
4
10 more added
Sold out
4
12 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 49 institutions
Q1 2021: 57 institutionsQ2 2021: 48 institutionsQ3 2021: 43 institutionsQ4 2021: 45 institutionsQ1 2022: 39 institutionsQ2 2022: 43 institutionsQ3 2022: 35 institutionsQ4 2022: 48 institutionsQ1 2023: 42 institutionsQ2 2023: 50 institutionsQ3 2023: 49 institutionsQ4 2023: 52 institutionsQ1 2024: 104 institutionsQ2 2024: 105 institutionsQ3 2024: 127 institutionsQ4 2024: 135 institutionsQ1 2025: 112 institutionsQ2 2025: 98 institutionsQ3 2025: 105 institutionsQ4 2025: 117 institutionsQ1 2026: 138 institutionsQ2 2026: 131 institutions
Value heldQ3 2023: $9.99M
Q1 2021: $20.2MQ2 2021: $13.9MQ3 2021: $9.99MQ4 2021: $6.78MQ1 2022: $5.79MQ2 2022: $5.19MQ3 2022: $3.70MQ4 2022: $4.26MQ1 2023: $17.8MQ2 2023: $22.0MQ3 2023: $9.99MQ4 2023: $14.7MQ1 2024: $294.6MQ2 2024: $384.9MQ3 2024: $654.9MQ4 2024: $150.7MQ1 2025: $96.4MQ2 2025: $146.3MQ3 2025: $150.1MQ4 2025: $105.0MQ1 2026: $333.1MQ2 2026: $297.6M
Institutions holding CATX and their total value by quarter
QuarterHoldersValue
Q2 2026131$297.6M
Q1 2026138$333.1M
Q4 2025117$105.0M
Q3 2025105$150.1M
Q2 202598$146.3M
Q1 2025112$96.4M
Q4 2024135$150.7M
Q3 2024127$654.9M
Q2 2024105$384.9M
Q1 2024104$294.6M
Q4 202352$14.7M
Q3 202349$9.99M
Q2 202350$22.0M
Q1 202342$17.8M
Q4 202248$4.26M
Q3 202235$3.70M
Q2 202243$5.19M
Q1 202239$5.79M
Q4 202145$6.78M
Q3 202143$9.99M
Q2 202148$13.9M
Q1 202157$20.2M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q2 2023.

Institutions holding CATX in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc12,818,626$3.51M0.00%+99,189+0.8%Added
Baker Bros. Advisors LP7,639,703$2.09M0.01%+5,320,417+229.4%Added
BlackRock Inc.4,538,389$1.24M0.00%−799,393−15.0%Reduced
Perkins Capital Management Inc2,671,644$731.0K0.72%−3,000−0.1%Reduced
Geode Capital Management, LLC2,516,649$689.0K0.00%+66,750+2.7%Added
Osterweis Capital Management Inc1,582,100$433.0K0.03%00.0%Unchanged
HighTower Advisors, LLC1,147,038$314.0K0.00%00.0%Unchanged
State Street Corp671,524$183.8K0.00%+21,100+3.2%Added
Taylor & Morgan Wealth Management, LLC575,000$157.4K0.14%−20,582−3.5%Reduced
Northern Trust Corp393,312$107.6K0.00%−1,682−0.4%Reduced
Renaissance Technologies LLC367,646$101.0K0.00%−69,280−15.9%Reduced
Bridgeway Capital Management, LLC184,000$50.4K0.00%00.0%Unchanged
Bank of New York Mellon Corp154,238$42.2K0.00%00.0%Unchanged
Jane Street Group, LLC146,801$40.2K0.00%+134,582+1,101.4%Added
Creative Planning129,500$35.4K0.00%−5,000−3.7%Reduced
Charles Schwab Investment Management Inc116,009$31.8K0.00%00.0%Unchanged
Wealth Effects LLC110,000$30.1K0.01%00.0%Unchanged
HRT Financial LP102,708$28.0K0.00%+102,708New
Two Sigma Securities, LLC76,565$21.0K0.00%−24,206−24.0%Reduced
Cetera Investment Advisers65,000$17.8K0.00%00.0%Unchanged
Morgan Stanley56,967$15.6K0.00%−5,184−8.3%Reduced
Commonwealth Equity Services, LLC42,284$12.0K0.00%00.0%Unchanged
Thrivent Financial for Lutherans40,000$11.0K0.00%00.0%Unchanged
JDM Financial Group LLC35,000$9.58K0.01%00.0%Unchanged
Wells Fargo & Company34,617$9.47K0.00%+351+1.0%Added
Two Sigma Advisers, LP32,600$8.92K0.00%−3,600−9.9%Reduced
LPL Financial LLC26,658$7.30K0.00%−7,480−21.9%Reduced
Wealth Advisors of Iowa, LLC20,000$5.47K0.00%00.0%Unchanged
TMD Wealth Management, LLC20,000$5.47K0.00%00.0%Unchanged
Susquehanna International Group, LLP19,338$5.29K0.00%+2,868+17.4%Added
FMR LLC18,004$4.93K0.00%+17,977+66,581.5%Added
Raymond James Financial Services Advisors, Inc.17,500$4.79K0.00%−1,000−5.4%Reduced
Ameriprise Financial Inc15,000$4.11K0.00%00.0%Unchanged
Mendota Financial Group, LLC15,000$4.11K0.00%00.0%Unchanged
Congress Wealth Management LLC15,000$4.11K0.00%00.0%Unchanged
KilterHowling LLC14,625$4.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)14,047$3.85K0.00%+2,824+25.2%Added
Goldman Sachs Group Inc13,373$3.66K0.00%+13,373New
Great Valley Advisor Group, Inc.12,000$3.28K0.00%00.0%Unchanged
Virtu Financial LLC12,729$3.00K0.00%+12,729New
Auxier Asset Management10,218$2.80K0.00%00.0%Unchanged
Capital Advisors Inc10,000$2.74K0.00%00.0%Unchanged
JNBA Financial Advisors5,000$1.37K0.00%00.0%Unchanged
Royal Bank of Canada2,229$1.00K0.00%+1,967+750.8%Added
TD Waterhouse Canada Inc.2,000$5280.00%00.0%Unchanged
UBS Group AG680$1860.00%−161−19.1%Reduced
Chilton Capital Management LLC500$1370.00%00.0%Unchanged
JPMorgan Chase & Co330$900.00%+330New
BNP Paribas Arbitrage, SA38$100.00%00.0%Unchanged
Portland Investment Counsel Inc.0$00.00%−1,034,100−100.0%Sold out
Citadel Advisors LLC0$00.00%−166,779−100.0%Sold out
Cerity Partners LLC0$00.00%−40,000−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−100−100.0%Sold out
BerganKDV Wealth Management, LLC––––Not filed